Archive for July, 2022

  • Isofol receives approval of biomarker analysis patent and intention-to-grant patent application for study dose regimen in Europe

    GOTHENBURG, Sweden, July 26, 2022 – Isofol Medical AB (http://isofol.se/en/) (publ) (Nasdaq Stockholm: ISOFOL), today announced the European approval for a…

    by